Jeffrey E. Russel

Array ( [id] => 5446942 [patent_doc_number] => 20090048168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'INHIBITORS OF BCL-2' [patent_app_type] => utility [patent_app_number] => 12/190979 [patent_app_country] => US [patent_app_date] => 2008-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14847 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048168.pdf [firstpage_image] =>[orig_patent_app_number] => 12190979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8928461 [patent_doc_number] => 20130184221 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-07-18 [patent_title] => 'Kinase Inhibitors And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/188109 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 32681 [patent_no_of_claims] => 134 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12188109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8928461 [patent_doc_number] => 20130184221 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-07-18 [patent_title] => 'Kinase Inhibitors And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/188109 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 32681 [patent_no_of_claims] => 134 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12188109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713270 [patent_doc_number] => 08399410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Methods and devices for desmopressin drug delivery' [patent_app_type] => utility [patent_app_number] => 12/186886 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10785 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12186886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5429077 [patent_doc_number] => 20090088387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'COMPOSITION FOR LONG-ACTING PEPTIDE ANALOGS' [patent_app_type] => utility [patent_app_number] => 12/184186 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 19821 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20090088387.pdf [firstpage_image] =>[orig_patent_app_number] => 12184186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265498 [patent_doc_number] => 20090118183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES' [patent_app_type] => utility [patent_app_number] => 12/178583 [patent_app_country] => US [patent_app_date] => 2008-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 41553 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118183.pdf [firstpage_image] =>[orig_patent_app_number] => 12178583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415845 [patent_doc_number] => 20090041732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Survivin Peptides As Cancer Vaccines' [patent_app_type] => utility [patent_app_number] => 12/176052 [patent_app_country] => US [patent_app_date] => 2008-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6053 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041732.pdf [firstpage_image] =>[orig_patent_app_number] => 12176052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 31729 [patent_doc_number] => 07790147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Peptide-based conditioners and colorants for hair, skin, and nails' [patent_app_type] => utility [patent_app_number] => 12/174694 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24893 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790147.pdf [firstpage_image] =>[orig_patent_app_number] => 12174694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995001 [patent_doc_number] => 08518885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Heterocyclic peptide ketoamides' [patent_app_type] => utility [patent_app_number] => 12/866541 [patent_app_country] => US [patent_app_date] => 2008-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18408 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12866541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285858 [patent_doc_number] => 20090099533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'VIRUS DERIVED ANTIMICROBIAL PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/171806 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 21476 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099533.pdf [firstpage_image] =>[orig_patent_app_number] => 12171806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4639546 [patent_doc_number] => 08017573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-13 [patent_title] => 'Adiponectin receptor fragments and methods of use' [patent_app_type] => utility [patent_app_number] => 12/169983 [patent_app_country] => US [patent_app_date] => 2008-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 9984 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/017/08017573.pdf [firstpage_image] =>[orig_patent_app_number] => 12169983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570414 [patent_doc_number] => 20090253792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'ACTIVE AGENT DELIVERY SYSTEMS AND METHODS FOR PROTECTING AND ADMINISTERING ACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 12/169389 [patent_app_country] => US [patent_app_date] => 2008-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 91222 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253792.pdf [firstpage_image] =>[orig_patent_app_number] => 12169389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495498 [patent_doc_number] => 20100286069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'CATIONIC PEPTIDE FOR DELIVERING AN AGENT INTO A CELL' [patent_app_type] => utility [patent_app_number] => 12/666787 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16044 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286069.pdf [firstpage_image] =>[orig_patent_app_number] => 12666787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759909 [patent_doc_number] => 20080312135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'MIXTURES OF DRUG-OLIGOMER CONJUGATES COMPRISING POLYETHYLENE GLYCOL, USES THEREOF, AND METHODS OF MAKING SAME' [patent_app_type] => utility [patent_app_number] => 12/141466 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 51983 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312135.pdf [firstpage_image] =>[orig_patent_app_number] => 12141466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279174 [patent_doc_number] => 20090131306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'CHEMICALLY MODIFIED CYCLIC PEPTIDES CONTAINING CELL ADHESION RECOGNITION (CAR) SEQUENCES AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/139270 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18352 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131306.pdf [firstpage_image] =>[orig_patent_app_number] => 12139270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309792 [patent_doc_number] => 20090017073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof' [patent_app_type] => utility [patent_app_number] => 12/155564 [patent_app_country] => US [patent_app_date] => 2008-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 11269 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017073.pdf [firstpage_image] =>[orig_patent_app_number] => 12155564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515381 [patent_doc_number] => 20090215688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'GLP-I Agonist And Cardiovascular Complications' [patent_app_type] => utility [patent_app_number] => 12/133463 [patent_app_country] => US [patent_app_date] => 2008-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6055 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215688.pdf [firstpage_image] =>[orig_patent_app_number] => 12133463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518465 [patent_doc_number] => 20100203012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'IAP BIR DOMAIN BINDING COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/601997 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27675 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203012.pdf [firstpage_image] =>[orig_patent_app_number] => 12601997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231575 [patent_doc_number] => 20100184709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'MALT1 SPECIFIC CLEAVAGE IN ASSAY AND SCREENING METHOD' [patent_app_type] => utility [patent_app_number] => 12/602590 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12993 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184709.pdf [firstpage_image] =>[orig_patent_app_number] => 12602590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650878 [patent_doc_number] => 20110300147 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2011-12-08 [patent_title] => 'Inhibiting tumor cell invasion, metastasis and angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/156123 [patent_app_country] => US [patent_app_date] => 2008-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 47032 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0300/20110300147.pdf [firstpage_image] =>[orig_patent_app_number] => 12156123 [rel_patent_id] =>[rel_patent_doc_number] =>)